Active pharmaceutical licensor around the world

Expressions for a healthy life

Our Products

Discover Intas B2B extensive pipeline and dossier portfolio differentiated in three main areas: Generics, Biosimilars and Added Value Medicines (AVM).

Generics

More than 140 dossiers approved in different jurisdictions

Biosimilars

Intas biologics business unit develops and manufactures high-quality biosimilars that are commercialized across all continents

Added Value Medicines

Intas AVM business unit is constantly looking for innovative formulas

Intas B2B around the world

Intas B2B is composed by a fully-fledge support global team of 50 people (from our Global offices in Barcelona and, also spread around the globe) to cover the demand of our customers.